Determination of the critical region of listeriolysin O (LLO) for the cytokine-inducing activity and application of LLO to vaccination with killed BCG.
Determination of the critical region of listeriolysin O (LLO) for the cytokine-inducing activity and application of LLO to vaccination with killed BCG.
批准号:
11670263
负责人:
KAWAMURA Ikuo
金额:
$2.43万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Listeriolysin O (LLO) is demonstrated to be a mojor virulence factor of Listeria monocytogenes and is one of the member of cholesterol-binding cytolysins. we have reported that LLO induces endogenous Th1-type cytokine productions independent of the membrane lytic activity. It suggests that LLO may play a role as an adjuvant to promote the generation of protective immunity if it does not exert the cytolytic activity in vivo. In the present study, therefore, we attempted to determine the critical region of LLO only for the cytokine-inducing activity and evaluated its effectiveness as an adjuvant by administration of LLO encapsulated with liposome containing cholesterol.LLO deleted for the fourth domain (LLO415), which is important for expression of the cytolytic activity, showed IFN-γ inducing activity. However, recombinant fourth domain did not induce the cytokine production. The activity of LLO415 was considerably suppressed when the N-terminal portion was further deleted. These data indicated that the N-terminus of LLO but not C-terminal fourth domain is critical for the cytokine-inducing activity. The activity of LLO was not observed in spleen cells of C3H/HeJ mice and was blocked by anti-CD14 antibody, suggesting that the signal of LLO may transduce via a signaling pathway of LPS.Moreover, immunoprecipitation revealed that LLO bound to two molecules on J774.1 cells, of which molecular weights are approximately 50-60kDa. We believe that these molecules are involved in the signal transduction of LLO.To determine the efficacy of LLO as an adjuvant, C3H/HeN mice were immunized with killed BCG along with LLO encapsulated in the liposome. The LLO showed no cytolytic activity and promoted generation of protective T cells, suggesting that LLO functions as the adjuvant to promote Th1-type host resistance. On the other hand, because LLO415 was not trapped in liposome well, the adjuvant activity was remained to be elucidated.
期刊论文(16)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
河村伊久雄: "リステリア膜傷害毒素listeriolysin OによるTh1細胞の誘導"臨床免疫. 34. 153-160 (2000)
Ikuo Kawamura:“李斯特菌膜损伤毒素李斯特菌溶血素 O 诱导 Th1 细胞”《临床免疫学》34. 153-160 (2000)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
河村伊久雄: "結核 分担:結核菌のエスケープ機構と宿主免疫応答"医薬ジャーナル. 414 (2001)
河村郁夫:《结核病分享:结核分枝杆菌逃逸机制和宿主免疫反应》医药杂志414(2001)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tachibana, T.: "Involvement of CD4+ T cells and macrophages in acquired protection against infection with Sporothrix schenkii in mice."Med.Mycol.. 37. 397-404 (1999)
Tachibana, T.:“CD4 T 细胞和巨噬细胞参与获得性保护,防止小鼠申基孢子丝菌感染。”Med.Mycol.. 37. 397-404 (1999)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Baba,H.: "Essential role of domain 4 of pneumolysin from Streptococcus pneumoniae in cytolytic activity as determined by truncated proteins."Biochem.Biophys.Res.Com.. 281. 37-44 (2001)
Baba,H.:“肺炎链球菌肺炎球菌溶血素结构域 4 在通过截短蛋白测定的细胞溶解活性中的重要作用。”Biochem.Biophys.Res.Com.. 281. 37-44 (2001)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
光山正雄: "結核 分担:結核と防御ワクチン"医薬ジャーナル. 414 (2001)
Masao Mitsuyama:“结核病分享:结核病和保护性疫苗”医药杂志 414 (2001)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 14 条
Regulatory mechanism of the macrophage function by mycobacterial secretory components
-
批准号:24590522
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.49万
-
财政年份:2012
-
负责人:KAWAMURA Ikuo
-
依托单位:
Regulatory mechanism of the generation of immune response to Mycobacterium tuberculosis infection
-
批准号:21590479
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2009
-
负责人:KAWAMURA Ikuo
-
依托单位:
Perturbation of macrophage function by virulence-associating determinants derived from Mycobacterium tuberculosis
-
批准号:19590443
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.83万
-
财政年份:2007
-
负责人:KAWAMURA Ikuo
-
依托单位:
Analysis for regulatory mechanism of macrophage functions by Mycobacterium tuberculosis
-
批准号:17590389
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2005
-
负责人:KAWAMURA Ikuo
-
依托单位:
Characterization of a novel BCG-derived TLR2 ligand capable of preferentially inducing Th1 cytokine production and investigation of the cytokine-inducing mechanism
-
批准号:15590385
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2003
-
负责人:KAWAMURA Ikuo
-
依托单位:
Possible involvement of M. bovis BCG-producing TLR2 ligand to generate protective immunity by inducing TH1 cytokine productions
-
批准号:13670270
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$0.58万
-
财政年份:2001
-
负责人:KAWAMURA Ikuo
-
依托单位:
Identification of a novel protectiveantigen of Mycobacterium bovis and its application to the host defense
-
批准号:06670285
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.15万
-
财政年份:1994
-
负责人:KAWAMURA Ikuo
-
依托单位:
国内基金
海外基金
登录
查看更多内容
内皮细胞源性CXCL10介导IFN-γ依赖性巨噬细胞代谢重编程在抗汉塞巴尔通体感染中的作用机制研究
-
批准号:2026JJ81684
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:贺潇瑾
-
依托单位:
KW6002通过调控IFN-γ炎症通路及类淋巴功能改善MS-ON病理的机制研究
-
批准号:JCZRQNB202600561
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
IFN-γ微球经肝动脉递送协同PD-1抑制剂抗肝癌的增效机制与免疫微环境重塑
-
批准号:2026JJ80633
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王小军
-
依托单位:
IFN-γ信号激活通过自噬缓解CDDP诱导的心脏毒性
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:曹莹莹
-
依托单位:
IFN- α 通过SOCS3/JAK2/STAT5通路调控
H3N2流感病毒引起的鼻黏膜嗜酸性粒细
胞浸润性炎症的分子机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:洪海裕
-
依托单位:
短程放疗通过IFN-β-CXCR3/MHC-II轴协同直肠癌化疗免疫治疗的分子机制研究
-
批准号:JCZRLH202500227
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
弓形虫TISAM调控宿主巨噬细胞IFN-γ受体亚基IFN-γR2参与免疫逃避的机制研究
-
批准号:MS25H190010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:郑斌
-
依托单位:
IFN-γ/JAK/STAT1在少突胶质细胞前体细胞增殖、分化以及髓鞘再生中的作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:索娜
-
依托单位:
组织驻留记忆T细胞通过IFN-γ介导的成纤维细胞异常活化导致慢性移植物抗宿主病的机制研究
-
批准号:QN25H080009
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:杨露欣
-
依托单位:
光调控IFN-γ表达的细胞核靶向智能纳米平台联合aPD-L1用于抗肿瘤免疫
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:何霄
-
依托单位: